What is Cardinal Health's forward P/E?

Cardinal Health's forward P/E is 20.73: today's price over the analysts' average EPS estimate for the next twelve months, the earnings expected rather than those reported. By fiscal year, it trades at 21.6 times its FY2027 earnings and 19.3 times its FY2028 earnings.

What is Cardinal Health's PEG ratio?

Cardinal Health's PEG ratio is 1.20: its P/E of 34.97 over the 29.2% a year the analysts expect its earnings per share to grow from FY2026 to FY2029. Around 1 is often read as a P/E in line with the growth; above it, the price asks for more.

Cardinal Health
D
Quotes are delayed by 15 minutes

CAH

Arincen ScoreBeta75/100

75/100B

271.74

USD

3.96

(1.48%)

Post Trading·270.81USD-0.93(-0.34%)

Last updated: 6 Nov, 17:28 GMT-5 · Delayed 15 min

Fair value327.68Plus-17%246Price 271.74410

Q1 FY2027 results

EPS3.26+10.9%Revenue67.51B+1.3%

Q1 FY2027 results

Reported Thursday 5 November

EPS3.26Beat +10.9%(est. 2.94)Revenue67.51BBeat +1.3%(est. 66.67B)

Fair value327.68Plus-17%246Price 271.74410

Q1 FY2027 results

EPS3.26+10.9%Revenue67.51B+1.3%

Q1 FY2027 results

Reported Thursday 5 November

EPS3.26Beat +10.9%(est. 2.94)Revenue67.51BBeat +1.3%(est. 66.67B)

Overview Financials Forecast Earnings Dividends Company

Cardinal Health P/E ratio

Cardinal Health's P/E ratio is 34.97: its share price of 271.74 over its earnings per share of 7.77 over the last twelve months.

Today: 34.97
Forward P/E, next 12 months: 20.73
PEG ratio: 1.20
Median, 5 years: 32.19
Low, 5 years: 21.35
High, 5 years: 198.71

P/E ratio = price ÷ EPS (last 12 months) = 271.74 ÷ 7.77 = 34.97

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Cardinal Health's P/E high compared with its own history?

Cardinal Health's P/E of 35.0 is above the middle of its 5-year range (21.4 to 198.7, median 32.2). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history.

5-year range of the daily P/E

Median 32.2

Today 35.0

21.4

198.7

The price against its P/E range

At its 5-year high P/E (198.7)At its median P/E (32.2)At its 5-year low P/E (21.4)Price

Each line is the earnings per share of the day times one P/E of the last five years: the price near the top line is near the most it was paid for those earnings, near the bottom line the least.

Growth a year: the past against what analysts expect

EPSSlower
Expected, to FY2029 29.2%Past 5 years 28.3%Past 3 years 79.0%
RevenueSlower
Expected, to FY2029 5.4%Past 5 years 9.4%Past 3 years 7.4%

	Past 5 years	Past 3 years	Expected, to FY2029	Expected against the past
EPS	28.3%	79.0%	29.2%	Slower
Revenue	9.4%	7.4%	5.4%	Slower

Buyers pay about the usual price for each point of growth: a PEG of 1.2 on expected growth against 1.1 on its median P/E and past five years' growth.

What changed in 5 years

Debt is lower than in FY2021: 2.9 times EBITDA against 5.2.
Buybacks: EPS grew ⁦28.3%⁩ a year since FY2021 against ⁦22.9%⁩ for net income; the falling share count added about 5.4 points a year.
Operating margin is about the same as in FY2021: ⁦1.0%⁩ against ⁦0.3%⁩.
Unusual tax: FY2021 at ⁦-89.5%⁩, FY2023 at ⁦50.1%⁩ against a usual ⁦25.3%⁩, which moves that year's profit and the P/E readings that include it.
GMPD grew from ⁦0.0%⁩ of revenue in FY2021 to ⁦5.0%⁩ in FY2026.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal year	Period ending	P/E ratio	Forward P/E	Market cap	Net income
FY2028 · Estimate	30 Jun 2028	19.31	—	—	—
FY2027 · Estimate	30 Jun 2027	21.62	—	—	—
Today		34.97	20.73	62.92B	1.81B
FY2026	30 Jun 2026	32.88	18.89	56.06B	1.71B
FY2025	30 Jun 2025	25.80	15.58	40.49B	1.57B
FY2024	30 Jun 2024	28.08	12.01	23.95B	853.00M
FY2023	30 Jun 2023	74.57	17.99	24.68B	331.00M
FY2022	30 Jun 2022	—	9.59	14.58B	-933.00M
FY2021	30 Jun 2021	27.24	9.59	16.67B	612.00M
FY2020	30 Jun 2020	—	8.71	15.29B	-3.69B
FY2019	30 Jun 2019	10.45	8.88	14.27B	1.37B
FY2018	30 Jun 2018	59.01	12.22	15.28B	259.00M
FY2017	30 Jun 2017	19.09	15.81	24.70B	1.29B
FY2016	30 Jun 2016	17.83	14.57	25.51B	1.43B
FY2015	30 Jun 2015	22.91	15.98	27.77B	1.21B
FY2014	30 Jun 2014	20.10	15.69	23.38B	1.16B
FY2013	30 Jun 2013	48.44	14.71	16.23B	335.00M
FY2012	30 Jun 2012	13.54	13.60	14.49B	1.07B
FY2011	30 Jun 2011	16.39	17.81	15.83B	966.00M
FY2010	30 Jun 2010	20.54	17.69	12.06B	587.00M
FY2009	30 Jun 2009	14.41	12.42	10.92B	758.20M
FY2008	30 Jun 2008	21.81	15.26	18.48B	847.20M
FY2007	30 Jun 2007	14.45	20.72	27.90B	1.93B
FY2006	30 Jun 2006	27.09	20.17	27.10B	1.00B
FY2005	30 Jun 2005	23.60	17.09	24.79B	1.05B
FY2004	30 Jun 2004	19.62	20.79	29.76B	1.52B
FY2003	30 Jun 2003	20.78	19.02	28.71B	1.38B
FY2002	30 Jun 2002	22.38	21.72	25.54B	1.14B
FY2001	30 Jun 2001	36.32	29.87	31.14B	857.40M
FY2000	30 Jun 2000	30.64	21.36	21.99B	717.80M
FY1999	30 Jun 1999	37.02	29.28	17.81B	481.00M
FY1998	30 Jun 1998	37.80	34.44	16.95B	448.50M
FY1997	30 Jun 1997	17.76	25.96	5.95B	334.80M
FY1996	30 Jun 1996	42.04	—	4.94B	117.60M
FY1995	30 Jun 1995	13.71	—	1.95B	142.50M
FY1994	30 Jun 1994	54.97	—	1.93B	35.10M
FY1993	30 Jun 1993	16.10	—	540.80M	33.60M
FY1992	30 Jun 1992	22.94	—	577.97M	25.20M
FY1991	30 Jun 1991	29.00	—	504.60M	17.40M
FY1990	30 Jun 1990	21.58	—	276.21M	12.80M
FY1989	31 Mar 1989	12.32	—	108.38M	8.80M
FY1988	31 Mar 1988	11.40	—	75.24M	6.60M
FY1987	31 Mar 1987	16.77	—	90.55M	5.40M
FY1986	31 Mar 1986	17.93	—	107.57M	6.00M

Quarter	Period ending	P/E ratio	Forward P/E	Market cap	Net income
Q1 FY2027	30 Sept 2026	28.57	17.19	51.62B	1.81B
Q4 FY2026	30 Jun 2026	32.88	18.89	56.06B	1.71B
Q3 FY2026	31 Mar 2026	32.08	17.43	49.66B	1.55B
Q2 FY2026	31 Dec 2025	28.94	17.59	48.50B	1.68B
Q1 FY2026	30 Sept 2025	23.26	13.98	37.36B	1.61B
Q4 FY2025	30 Jun 2025	25.59	15.58	40.15B	1.57B
Q3 FY2025	31 Mar 2025	21.20	13.60	33.06B	1.56B
Q2 FY2025	31 Dec 2024	21.78	12.46	28.62B	1.31B
Q1 FY2025	30 Sept 2024	20.95	12.49	26.86B	1.28B
Q4 FY2024	30 Jun 2024	27.93	12.01	23.85B	854.00M
Q3 FY2024	31 Mar 2024	49.15	15.04	27.23B	554.00M
Q2 FY2024	31 Dec 2023	38.65	15.01	24.70B	639.00M
Q1 FY2024	30 Sept 2023	154.42	14.52	21.62B	140.00M
Q4 FY2023	30 Jun 2023	91.68	17.99	24.02B	262.00M
Q3 FY2023	31 Mar 2023	41.57	14.03	19.33B	465.00M
Q2 FY2023	31 Dec 2022	—	9.59	20.06B	-1.27B
Q1 FY2023	30 Sept 2022	—	9.59	18.07B	-1.09B
Q4 FY2022	30 Jun 2022	—	9.59	14.27B	-932.00M
Q3 FY2022	31 Mar 2022	—	9.59	15.59B	-954.00M
Q2 FY2022	31 Dec 2021	25.84	9.59	14.37B	556.00M
Q1 FY2022	30 Sept 2021	12.48	9.59	14.20B	1.14B
Q4 FY2021	30 Jun 2021	27.05	9.59	16.56B	612.00M
Q3 FY2021	31 Mar 2021	15.37	9.59	17.74B	1.15B
Q2 FY2021	31 Dec 2020	11.37	9.59	15.75B	1.39B
Q1 FY2021	30 Sept 2020	14.11	8.11	13.76B	975.00M
Q4 FY2020	30 Jun 2020	—	8.71	15.24B	-3.69B
Q3 FY2020	31 Mar 2020	—	8.24	14.00B	-4.16B
Q2 FY2020	31 Dec 2019	—	8.96	14.77B	-4.21B
Q1 FY2020	30 Sept 2019	—	8.62	13.95B	-4.15B
Q4 FY2019	30 Jun 2019	10.38	8.88	14.17B	1.37B
Q3 FY2019	31 Mar 2019	3,659.44	9.17	14.64B	4.00M
Q2 FY2019	31 Dec 2018	—	12.22	13.34B	-37.00M
Q1 FY2019	30 Sept 2018	22.35	12.22	16.45B	736.00M
Q4 FY2018	30 Jun 2018	58.40	12.22	15.13B	259.00M
Q3 FY2018	31 Mar 2018	11.52	12.22	19.62B	1.70B
Q2 FY2018	31 Dec 2017	10.55	12.22	19.30B	1.83B
Q1 FY2018	30 Sept 2017	19.21	13.46	21.15B	1.10B
Q4 FY2017	30 Jun 2017	19.03	15.81	24.62B	1.29B
Q3 FY2017	31 Mar 2017	19.07	16.20	25.77B	1.35B
Q2 FY2017	31 Dec 2016	16.89	14.01	22.89B	1.36B
Q1 FY2017	30 Sept 2016	18.32	14.81	24.86B	1.36B
Q4 FY2016	30 Jun 2016	17.66	14.57	25.28B	1.43B
Q3 FY2016	31 Mar 2016	19.37	15.40	26.88B	1.39B
Q2 FY2016	31 Dec 2015	21.48	16.87	29.37B	1.37B
Q1 FY2016	30 Sept 2015	18.95	14.60	25.20B	1.33B
Q4 FY2015	30 Jun 2015	22.78	15.98	27.60B	1.21B
Q3 FY2015	31 Mar 2015	25.81	17.99	29.79B	1.15B
Q2 FY2015	31 Dec 2014	24.20	16.80	26.72B	1.10B
Q1 FY2015	30 Sept 2014	23.12	16.33	25.17B	1.09B
Q4 FY2014	30 Jun 2014	19.98	15.69	23.24B	1.16B
Q3 FY2014	31 Mar 2014	69.78	17.15	23.93B	343.00M
Q2 FY2014	31 Dec 2013	61.09	17.61	22.85B	374.00M
Q1 FY2014	30 Sept 2013	44.00	14.89	17.73B	403.00M
Q4 FY2013	30 Jun 2013	48.26	14.71	16.17B	335.00M
Q3 FY2013	31 Mar 2013	12.33	13.09	14.27B	1.16B
Q2 FY2013	31 Dec 2012	12.24	13.07	14.00B	1.14B
Q1 FY2013	30 Sept 2012	12.19	12.49	13.47B	1.11B
Q4 FY2012	30 Jun 2012	13.54	13.60	14.49B	1.07B
Q3 FY2012	31 Mar 2012	14.28	14.59	14.87B	1.04B
Q2 FY2012	31 Dec 2011	14.63	14.40	14.01B	957.90M
Q1 FY2012	30 Sept 2011	15.89	15.60	14.44B	908.80M
Q4 FY2011	30 Jun 2011	16.21	17.81	15.66B	966.20M
Q3 FY2011	31 Mar 2011	15.05	17.22	14.33B	952.60M
Q2 FY2011	31 Dec 2010	14.35	17.20	13.32B	927.90M
Q1 FY2011	30 Sept 2010	12.22	16.01	11.53B	943.20M
Q4 FY2010	30 Jun 2010	19.98	17.69	11.73B	587.00M
Q3 FY2010	31 Mar 2010	19.76	17.67	12.92B	653.90M
Q2 FY2010	31 Dec 2009	17.97	14.80	11.57B	644.10M
Q1 FY2010	30 Sept 2009	16.51	11.56	9.62B	582.90M
Q4 FY2009	30 Jun 2009	13.41	12.42	10.95B	816.90M
Q3 FY2009	31 Mar 2009	12.90	11.71	11.27B	874.20M
Q2 FY2009	31 Dec 2008	11.99	11.82	12.32B	1.03B
Q1 FY2009	30 Sept 2008	14.86	15.65	17.58B	1.18B
Q4 FY2008	30 Jun 2008	13.97	15.26	18.34B	1.31B
Q3 FY2008	31 Mar 2008	9.84	15.50	18.67B	1.90B
Q2 FY2008	31 Dec 2007	13.39	17.01	20.71B	1.55B
Q1 FY2008	30 Sept 2007	11.48	18.38	22.52B	1.96B
Q4 FY2007	30 Jun 2007	13.28	20.72	25.64B	1.93B
Q3 FY2007	31 Mar 2007	18.05	21.75	28.79B	1.59B
Q2 FY2007	31 Dec 2006	15.05	19.53	25.91B	1.72B
Q1 FY2007	30 Sept 2006	20.66	20.26	26.59B	1.29B
Q4 FY2006	30 Jun 2006	20.91	20.17	26.02B	1.24B
Q3 FY2006	31 Mar 2006	33.35	23.04	31.23B	936.60M
Q2 FY2006	31 Dec 2005	25.19	20.96	29.25B	1.16B
Q1 FY2006	30 Sept 2005	25.60	19.08	27.04B	1.06B
Q4 FY2005	30 Jun 2005	23.37	17.09	24.55B	1.05B
Q3 FY2005	31 Mar 2005	20.46	20.79	24.09B	1.18B
Q2 FY2005	31 Dec 2004	20.56	20.79	25.13B	1.22B
Q1 FY2005	30 Sept 2004	13.46	20.79	18.90B	1.40B
Q4 FY2004	30 Jun 2004	20.00	20.79	30.24B	1.51B
Q3 FY2004	31 Mar 2004	19.93	20.43	29.86B	1.50B
Q2 FY2004	31 Dec 2003	18.06	18.12	26.49B	1.47B
Q1 FY2004	30 Sept 2003	17.69	17.29	25.72B	1.45B
Q4 FY2003	30 Jun 2003	20.06	19.02	28.32B	1.41B
Q3 FY2003	31 Mar 2003	19.14	17.57	25.59B	1.34B
Q2 FY2003	31 Dec 2002	20.89	19.05	26.16B	1.25B
Q1 FY2003	30 Sept 2002	23.76	20.95	27.75B	1.17B
Q4 FY2002	30 Jun 2002	22.04	21.72	24.82B	1.13B
Q3 FY2002	31 Mar 2002	29.83	26.29	32.32B	1.08B
Q2 FY2002	31 Dec 2001	28.95	25.14	29.09B	1.00B
Q1 FY2002	30 Sept 2001	35.51	30.33	33.05B	930.60M
Q4 FY2001	30 Jun 2001	36.18	29.87	31.02B	857.40M
Q3 FY2001	31 Mar 2001	35.88	27.92	28.66B	798.80M
Q2 FY2001	31 Dec 2000	35.07	28.75	27.83B	793.40M
Q1 FY2001	30 Sept 2000	34.05	25.45	25.80B	757.70M
Q4 FY2000	30 Jun 2000	29.07	21.36	20.54B	706.50M
Q3 FY2000	31 Mar 2000	20.37	14.58	13.47B	661.20M
Q2 FY2000	31 Dec 1999	25.14	16.92	13.43B	534.10M
Q1 FY2000	30 Sept 1999	30.37	21.73	15.25B	502.10M
Q4 FY1999	30 Jun 1999	37.88	29.28	17.98B	474.80M
Q3 FY1999	31 Mar 1999	47.20	31.48	18.69B	396.00M
Q2 FY1999	31 Dec 1998	45.39	37.86	21.05B	463.80M
Q1 FY1999	30 Sept 1998	34.32	36.05	13.82B	402.80M
Q4 FY1998	30 Jun 1998	33.59	34.44	12.68B	377.40M
Q3 FY1998	31 Mar 1998	26.07	34.00	9.61B	368.70M
Q2 FY1998	31 Dec 1997	39.74	30.47	9.94B	250.20M
Q1 FY1998	30 Sept 1997	45.15	30.41	9.51B	210.60M
Q4 FY1997	30 Jun 1997	34.61	25.96	6.27B	181.10M
Q3 FY1997	31 Mar 1997	33.84	—	5.15B	152.10M
Q2 FY1997	31 Dec 1996	41.82	—	6.29B	150.40M
Q1 FY1997	30 Sept 1996	43.68	—	5.73B	131.20M
Q4 FY1996	30 Jun 1996	44.86	—	5.02B	111.90M
Q3 FY1996	31 Mar 1996	31.40	—	3.18B	101.20M
Q2 FY1996	31 Dec 1995	30.54	—	2.76B	90.30M
Q1 FY1996	30 Sept 1995	26.85	—	2.40B	89.50M
Q4 FY1995	30 Jun 1995	22.99	—	1.95B	85.00M
Q3 FY1995	31 Mar 1995	25.57	—	2.03B	79.40M
Q2 FY1995	31 Dec 1994	42.92	—	1.91B	44.60M
Q1 FY1995	30 Sept 1994	52.17	—	1.81B	34.60M
Q4 FY1994	30 Jun 1994	42.23	—	1.17B	27.80M
Q3 FY1994	31 Mar 1994	58.01	—	1.10B	19.00M
Q2 FY1994	31 Dec 1993	28.98	—	1.12B	38.50M
Q1 FY1994	30 Sept 1993	25.08	—	890.36M	35.50M
Q4 FY1993	30 Jun 1993	14.94	—	527.28M	35.30M
Q3 FY1993	31 Mar 1993	17.22	—	578.59M	33.60M
Q2 FY1993	31 Dec 1992	18.15	—	573.60M	31.60M
Q1 FY1993	30 Sept 1992	18.41	—	555.85M	30.20M
Q4 FY1992	30 Jun 1992	23.47	—	619.59M	26.40M
Q3 FY1992	31 Mar 1992	25.46	—	641.65M	25.20M
Q2 FY1992	31 Dec 1991	23.21	—	522.17M	22.50M
Q1 FY1992	30 Sept 1991	33.09	—	678.40M	20.50M
Q4 FY1991	30 Jun 1991	31.16	—	592.08M	19.00M
Q3 FY1991	31 Mar 1991	28.80	—	501.05M	17.40M
Q2 FY1991	31 Dec 1990	20.63	—	325.93M	15.80M
Q1 FY1991	30 Sept 1990	19.72	—	287.86M	14.60M
Q4 FY1990	30 Jun 1990	17.80	—	270.60M	15.20M
Q3 FY1990	31 Mar 1990	16.71	—	239.02M	14.30M
Q2 FY1990	31 Dec 1989	18.89	—	245.52M	13.00M
Q1 FY1990	30 Sept 1989	18.14	—	215.90M	11.90M
Q4 FY1989	30 Jun 1989	20.95	—	196.96M	9.40M
Q3 FY1989	31 Mar 1989	12.28	—	108.04M	8.80M
Q2 FY1989	31 Dec 1988	10.95	—	90.92M	8.30M
Q1 FY1989	30 Sept 1988	12.89	—	99.22M	7.70M
Q4 FY1988	30 Jun 1988	11.07	—	79.68M	7.20M
Q3 FY1988	31 Mar 1988	11.77	—	77.68M	6.60M
Q2 FY1988	31 Dec 1987	8.81	—	51.99M	5.90M
Q1 FY1988	30 Sept 1987	15.63	—	84.43M	5.40M
Q4 FY1987	30 Jun 1987	16.71	—	91.92M	5.50M
Q3 FY1987	31 Mar 1987	17.60	—	96.78M	5.50M
Q2 FY1987	31 Dec 1986	12.59	—	76.80M	6.10M
Q1 FY1987	30 Sept 1986	12.54	—	80.26M	6.40M
Q4 FY1986	30 Jun 1986	17.22	—	106.76M	6.20M
Q3 FY1986	31 Mar 1986	—	—	111.19M	—
Q2 FY1986	31 Dec 1985	—	—	85.96M	—
Q1 FY1986	30 Sept 1985	—	—	71.78M	—

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

Common questions about Cardinal Health's P/E ratio

Source: Financial Modeling Prep

Cardinal Health
D
Quotes are delayed by 15 minutes

CAH

Cardinal Health P/E ratio

Is Cardinal Health's P/E high compared with its own history?

The price against its P/E range

Growth a year: the past against what analysts expect

What changed in 5 years

P/E ratio by year and by quarter

Common questions about Cardinal Health's P/E ratio

What is Cardinal Health's P/E ratio?

Is Cardinal Health's P/E ratio high or low?

What is Cardinal Health's forward P/E?

What is Cardinal Health's PEG ratio?

Need help?

Cardinal Health DQuotes are delayed by 15 minutes

CAH

Cardinal Health P/E ratio

Is Cardinal Health's P/E high compared with its own history?

P/E ratio by year and by quarter

Common questions about Cardinal Health's P/E ratio

What is Cardinal Health's P/E ratio?

Is Cardinal Health's P/E ratio high or low?

What is Cardinal Health's forward P/E?

What is Cardinal Health's PEG ratio?

Need help?

Cardinal Health
D
Quotes are delayed by 15 minutes